AMRN
AMARIN CORP PLC\UK
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Operating Income
$-50170000
↑ 45.3%
Revenue
$213.6M
↓ 6.5%
Gross Profit
$120.9M
↑ 48.5%
Net Income
$-38798000
↑ 52.8%
Total Liabilities
$211.5M
↑ 6.2%
EPS (Diluted)
$-0.09
↑ 55.0%
Shareholders' Equity
$459.3M
↓ 5.5%
Total Assets
$670.8M
↓ 2.1%

Recent SEC Filings

Form Type Filed Date Link
ARS 4/10/2026 View on SEC
DEF 14A 4/10/2026 View on SEC
4 4/2/2026 View on SEC
PRE 14A 3/30/2026 View on SEC
8-K 3/27/2026 View on SEC
10-K 3/2/2026 View on SEC
8-K 2/25/2026 View on SEC
4 2/3/2026 View on SEC
4 2/3/2026 View on SEC
4 2/3/2026 View on SEC

Company Information

Field Value
Ticker AMRN
Company Name AMARIN CORP PLC\UK
CIK 897448
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation X0
Phone 353 1 6699 020